SCHEMBL2478741

SCHEMBL2478741

O=C(Nc1cccc(F)c1)N1CCC(c2ccc(O)cc2O)CC1

nearest known ligand 0.67

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.67
MGLL Q99685 1/20 0.53
ALDH1A1 P00352 4/20 0.52
CYP2D6 P10635 3/20 0.52
LMNA P02545 1/20 0.51
USP2 O75604 3/20 0.51
CYP2C19 P33261 2/20 0.51
CYP3A4 P08684 3/20 0.50
CYP1A2 P05177 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
POLB P06746 1/20 0.49
MAPT P10636 1/20 0.49
CCR2 P41597 1/20 0.49
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2476185 0.88 CA12 (0.55) NPC1LMNACYP2C19CYP1A2SMN1; SMN2
SCHEMBL2480782 0.88 NPC1 (0.56) NPC1ALDH1A1LMNACYP2C19SMN1; SMN2
SCHEMBL2473719 0.87 NPC1 (0.66) NPC1MGLLALDH1A1CYP2D6LMNA
SCHEMBL2474761 0.81 RAB9A (0.60) NPC1LMNASMN1; SMN2MAPTKMT2A
SCHEMBL2476567 0.81 TSHR (0.56) NPC1LMNASMN1; SMN2MAPTKMT2A
SCHEMBL2476936 0.81 NPC1 (0.64) NPC1ALDH1A1LMNASMN1; SMN2MAPT
SCHEMBL2477929 0.81 SMN1; SMN2 (0.50) NPC1ALDH1A1CYP2C19SMN1; SMN2MEN1
SCHEMBL13841263 0.79 LMNA (0.81) NPC1ALDH1A1CYP2D6LMNAUSP2
SCHEMBL10368891 0.76 NPC1 (0.64) NPC1ALDH1A1CYP2D6LMNAUSP2
SCHEMBL2475564 0.76 FNTA (0.46) NPC1SMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2373620-A1 NOVEL 4-(AZACYCLOALKYL)BENZENE-1,3-DIOL COMPOUNDS AS TYROSINASE INHIBITORS, PROCESS FOR THE PREPARATION THEREOF AND USE THEREOF IN HUMAN MEDICINE AND IN COSMETICS Galderma Research & Development (FR) 2011-10-12 EP disclosed